Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities - PubMed (original) (raw)
Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities
D M Parry et al. Am J Hum Genet. 1996 Sep.
Abstract
Neurofibromatosis 2 (NF2) features bilateral vestibular schwannomas, other benign neural tumors, and cataracts. Patients in some families develop many tumors at an early age and have rapid clinical progression, whereas in other families, patients may not have symptoms until much later and vestibular schwannomas may be the only tumors. The NF2 gene has been cloned from chromosome 22q; most identified germ-line mutations result in a truncated protein and severe NF2. To look for additional mutations and clinical correlations, we used SSCP analysis to screen DNA from 32 unrelated patients. We identified 20 different mutations in 21 patients (66%): 10 nonsense mutations, 2 frameshifts, 7 splice-site mutations, and 1 large in-frame deletion. Clinical information on 47 patients from the 21 families included ages at onset and at diagnosis, numbers of meningiomas, spinal and skin tumors, and presence of cataracts and retinal abnormalities. We compared clinical findings in patients with nonsense or frameshift mutations to those with splice-site mutations. When each patient was considered as an independent random event, the two groups differed (P < or = .05) for nearly every variable. Patients with nonsense or frameshift mutations were younger at onset and at diagnosis and had a higher frequency and mean number of tumors, supporting the correlation between nonsense and frameshift mutations and severe NF2. When each family was considered as an independent random event, statistically significant differences between the two groups were observed only for mean ages at onset and at diagnosis. A larger data set is needed to resolve these discrepancies. We observed retinal hamartomas and/or epiretinal membranes in nine patients from five families with four different nonsense mutations. This finding, which may represent a new genotype-phenotype correlation, merits further study.
Similar articles
- Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
Feucht M, Kluwe L, Mautner VF, Richard G. Feucht M, et al. Arch Ophthalmol. 2008 Oct;126(10):1376-80. doi: 10.1001/archopht.126.10.1376. Arch Ophthalmol. 2008. PMID: 18852415 - Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.
Kluwe L, Bayer S, Baser ME, Hazim W, Haase W, Fünsterer C, Mautner VF. Kluwe L, et al. Hum Genet. 1996 Nov;98(5):534-8. doi: 10.1007/s004390050255. Hum Genet. 1996. PMID: 8882871 - Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, Evans DG. Selvanathan SK, et al. Clin Genet. 2010 Feb;77(2):163-70. doi: 10.1111/j.1399-0004.2009.01315.x. Epub 2009 Nov 23. Clin Genet. 2010. PMID: 19968670 - Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N, Whaley J, Seizinger BR. Kley N, et al. Glia. 1995 Nov;15(3):297-307. doi: 10.1002/glia.440150310. Glia. 1995. PMID: 8586465 Review. - CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
MacCollin M. MacCollin M. Brain Dev. 1995 Jul-Aug;17(4):231-8. doi: 10.1016/0387-7604(95)00044-c. Brain Dev. 1995. PMID: 7503383 Review.
Cited by
- Neurofibromatosis type 2.
Evans DG, Sainio M, Baser ME. Evans DG, et al. J Med Genet. 2000 Dec;37(12):897-904. doi: 10.1136/jmg.37.12.897. J Med Genet. 2000. PMID: 11106352 Free PMC article. Review. - Predictors of the risk of mortality in neurofibromatosis 2.
Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, Evans DG. Baser ME, et al. Am J Hum Genet. 2002 Oct;71(4):715-23. doi: 10.1086/342716. Epub 2002 Aug 22. Am J Hum Genet. 2002. PMID: 12235555 Free PMC article. - The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases.
Lasota J, Fetsch JF, Wozniak A, Wasag B, Sciot R, Miettinen M. Lasota J, et al. Am J Pathol. 2001 Apr;158(4):1223-9. doi: 10.1016/S0002-9440(10)64072-2. Am J Pathol. 2001. PMID: 11290539 Free PMC article. - Early prediction of functional prognosis in neurofibromatosis type 2 patients based on genotype-phenotype correlation with targeted deep sequencing.
Teranishi Y, Miyawaki S, Nakatomi H, Ohara K, Hongo H, Dofuku S, Okano A, Takayanagi S, Ota T, Yoshimura J, Qu W, Mitsui J, Morishita S, Tsuji S, Saito N. Teranishi Y, et al. Sci Rep. 2022 Jun 9;12(1):9543. doi: 10.1038/s41598-022-13580-9. Sci Rep. 2022. PMID: 35681071 Free PMC article. - Identification of mutations in the NF2 gene in Polish patients with neurofibromatosis type 2.
Łaniewski-Wołłk M, Gos M, Koziarski A, Szpecht-Potocka A. Łaniewski-Wołłk M, et al. J Appl Genet. 2008;49(3):297-300. doi: 10.1007/BF03195626. J Appl Genet. 2008. PMID: 18670066
References
- Arch Neurol. 1969 Feb;20(2):154-60 - PubMed
- Am J Hum Genet. 1994 Aug;55(2):314-20 - PubMed
- Birth Defects Orig Artic Ser. 1974;10(10):171-84 - PubMed
- Arch Ophthalmol. 1977 Nov;95(11):1990-2 - PubMed
- Neurology. 1980 Aug;30(8):851-9 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous